6 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18704561 | GENE DELIVERY COMPOSITION COMPRISING NITROGEN-DOPED GRAPHENE QUANTUM DOTS | BARBER, KIMBERLY | 1615 | Non-Final OA | Apr 25, 2024 |
| 18511106 | PHARMACEUTICAL COMPOSITION FOR PREVENTION, ALLEVIATION OR TREATMENT OF SARCOPENIA, CONTAINING ROR-alpha ACTIVATOR JC1-40 | CHAO, ALLEN | 1622 | Non-Final OA | Nov 16, 2023 |
| 18277637 | ANTI-CANCER PHARMACEUTICAL COMPOSITION FOR TARGETING HEAT SHOCK PROTEIN 70, CONTAINING INDOLOQUINAZOLIDINE ALKALOID | AULAKH, CHARANJIT | 1621 | Final Rejection | Aug 17, 2023 |
| 17995273 | PHARMACEUTICAL COMPOSITION FOR TREATING CANCER, CONTAINING LIPID-PHOTOTHERMAL NANOPARTICLE HAVING ANTIBODY BOUND TO SURFACE | XIAO, YAN | 1642 | Non-Final OA | Apr 04, 2023 |
| 18042806 | MRI CONTRAST MEDIUM INCLUDING CARBON-13-CONTAINING GRAPHENE QUANTUM DOT AND PREPARATION METHOD THEREFOR | YOUNG, MICAH PAUL | 1618 | Non-Final OA | Feb 24, 2023 |
| 18042801 | COMPOSITION FOR TREATING CORONAVIRUS DISEASE-19, COMPRISING PHENANTHROINDOLIZIDINE AND PHENANTHROQUINOLIZIDINE ALKALOID DERIVATIVES, OPTICAL ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS ACTIVE INGREDIENT | HUTTER, GILLIAN A | 1625 | Non-Final OA | Feb 24, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial